Abstract
Although retinoic acid (RA) is a potent agent that coordinates inhibition of proliferation with differentiation of many cell types, RA-mediated signaling pathways in osteosarcoma cell differentiation are uncharacterized. In this study, we show that in human U2OS osteosarcoma cells, decreased phosphorylation of RA receptor alpha (RARα) by RA treatment or overexpressing a phosphorylation-defective mutant RARαS77A results in the inhibition of proliferation and induction of differentiation, and that U2OS cells transduced with RARαS77A suppresses tumor formation in nude mice. Moreover, using different human primary osteosarcoma cells and human mesenchymal stem cells for gene expression analysis, we found that either RA or RARαS77A induces many of the same differentiation response pathways and signaling molecules involved in U2OS cell differentiation. In addition, overexpression of the fibroblast growth factor 8f (FGF8f), one of the downstream targets induced by both RA and RARαS77A in U2OS cells, inhibits proliferation and induces expression of osteoblastic differentiation regulators. Hence, these data strongly suggest that RA-suppressed phosphorylation of RARα induces FGF8f expression to mediate differentiation response pathway in U2OS osteosarcoma cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aranda A, Pascual A . (2001). Nuclear hormone receptors and gene expression. Physiol Rev 81: 1269–1304.
Bacci G, Ferrari S, Longhi A, Perin S, Forni C, Fabbri N et al. (2001). Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy. Eur J Cancer 37: 32–38.
Barroga E, Kadosawa T, Okumura M, Fujinaga T . (1999). Induction of functional differentiation and growth inhibition in vitro of canine osteosarcoma by 22-oxacalcitriol, calcitriol and all-trans retinoic acid. Zentralbl Veterinarmed A 46: 573–579.
Barroga EF, Kadosawa T, Okumura M, Fujinaga T . (2000). Influence of vitamin D and retinoids on the induction of functional differentiation in vitro of canine osteosarcoma clonal cells. Vet J 159: 186–193.
Bastien J, Rochette-Egly C . (2004). Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328: 1–16.
Beere HM, Hickman JA . (1993). Differentiation: a suitable strategy for cancer chemotherapy? Anticancer Drug Des 8: 299–322.
Benayahu D, Fried A, Shamay A, Cunningham N, Blumberg S, Wientroub S . (1994). Differential effects of retinoic acid and growth factors on osteoblastic markers and CD10/NEP activity in stromal-derived osteoblasts. J Cell Biochem 56: 62–73.
Brondani V, Hamy F . (2000). Retinoic acid switches differential expression of FGF8 isoforms in LNCaP cells. Biochem Biophys Res Commun 272: 98–103.
Brondani V, Klimkait T, Egly JM, Hamy F . (2002). Promoter of FGF8 reveals a unique regulation by unliganded RARalpha. J Mol Biol 319: 715–728.
Chambon P . (1996). A decade of molecular biology of retinoic acid receptors. FASEB J 10: 940–954.
Chen D, Zhao M, Mundy GR . (2004). Bone morphogenetic proteins. Growth Factors 22: 233–241.
Clark JC, Dass CR, Choong PF . (2008). A review of clinical and molecular prognostic factors in osteosarcoma. J Cancer Res Clin Oncol 134: 281–297.
Crowe DL, Kim R . (2002). A phosphorylation defective retinoic acid receptor mutant mimics the effects of retinoic acid on EGFR mediated AP-1 expression and cancer cell proliferation. Cancer Cell Int 2: 15.
Evans RM . (1988). The steroid and thyroid hormone receptor superfamily. Science 240: 889–895.
Fisher RP . (2005). Secrets of a double agent: CDK7 in cell-cycle control and transcription. J Cell Sci 118: 5171–5180.
Fisher RP, Morgan DO . (1994). A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78: 713–724.
Franceschi RT, Xiao G . (2003). Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways. J Cell Biochem 88: 446–454.
Gazit D, Ebner R, Kahn AJ, Derynck R . (1993). Modulation of expression and cell surface binding of members of the transforming growth factor-beta superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells. Mol Endocrinol 7: 189–198.
Gemel J, Gorry M, Ehrlich GD, MacArthur CA . (1996). Structure and sequence of human FGF8. Genomics 35: 253–257.
He Q, Peng H, Collins SJ, Triche TJ, Wu L . (2004). Retinoid-modulated MAT1 ubiquitination and CAK activity. FASEB J 18: 1734–1736.
Hoffman LM, Weston AD, Underhill TM . (2003). Molecular mechanisms regulating chondroblast differentiation. J Bone Joint Surg Am 85-A (Suppl 2): 124–132.
Hong SH, Kadosawa T, Nozaki K, Mochizuki M, Matsunaga S, Nishimura R et al. (2000a). In vitro retinoid-induced growth inhibition and morphologic differentiation of canine osteosarcoma cells. Am J Vet Res 61: 69–73.
Hong SH, Mochizuki M, Nishimura R, Sasaki N, Kadosawa T, Matsunaga S . (2000b). Differentiation induction of canine osteosarcoma cell lines by retinoids. Res Vet Sci 68: 57–62.
Horowitz MC, Bothwell AL, Hesslein DG, Pflugh DL, Schatz DG . (2005). B cells and osteoblast and osteoclast development. Immunol Rev 208: 141–153.
Jackson RA, Nurcombe V, Cool SM . (2006). Coordinated fibroblast growth factor and heparan sulfate regulation of osteogenesis. Gene 379: 79–91.
Jacobson A, Johansson S, Branting M, Melhus H . (2004). Vitamin A differentially regulates RANKL and OPG expression in human osteoblasts. Biochem Biophys Res Commun 322: 162–167.
Katoh M . (2006). Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades. Cancer Biol Ther 5: 1059–1064.
Leroy P, Krust A, Zelent A, Mendelsohn C, Garnier JM, Kastner P et al. (1991). Multiple isoforms of the mouse retinoic acid receptor alpha are generated by alternative splicing and differential induction by retinoic acid. EMBO J 10: 59–69.
Li Z, Li L . (2006). Understanding hematopoietic stem-cell microenvironments. Trends Biochem Sci 31: 589–595.
Liu F, Kohlmeier S, Wang CY . (2008). Wnt signaling and skeletal development. Cell Signal 20: 999–1009.
Luo P, Wang A, Payne KJ, Peng H, Wang JG, Parrish YK et al. (2007). Intrinsic retinoic acid receptor alpha-cyclin-dependent kinase-activating kinase signaling involves coordination of the restricted proliferation and granulocytic differentiation of human hematopoietic stem cells. Stem Cells 25: 2628–2637.
Mangelsdorf DJ, Umesono K, Kliewer SA, Borgmeyer U, Ong ES, Evans RM . (1991). A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell 66: 555–561.
Mattila MM, Harkonen PL . (2007). Role of fibroblast growth factor 8 in growth and progression of hormonal cancer. Cytokine Growth Factor Rev 18: 257–266.
Mayack SR, Wagers AJ . (2008). Osteolineage niche cells initiate hematopoietic stem cell mobilization. Blood 112: 519–531.
Melnick A, Licht JD . (1999). Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93: 3167–3215.
Nigg EA . (1996). Cyclin-dependent kinase 7: at the cross-roads of transcription, DNA repair and cell cycle control? Curr Opin Cell Biol 8: 312–317.
Orimo H, Shimada T . (2005). Regulation of the human tissue-nonspecific alkaline phosphatase gene expression by all-trans-retinoic acid in SaOS-2 osteosarcoma cell line. Bone 36: 866–876.
Ornitz DM, Marie PJ . (2002). FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 16: 1446–1465.
Rochette-Egly C, Adam S, Rossignol M, Egly JM, Chambon P . (1997). Stimulation of RAR alpha activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7. Cell 90: 97–107.
Rochette-Egly C, Plassat JL, Taneja R, Chambon P . (2000). The AF-1 and AF-2 activating domains of retinoic acid receptor-alpha (RARalpha) and their phosphorylation are differentially involved in parietal endodermal differentiation of F9 cells and retinoid-induced expression of target genes. Mol Endocrinol 14: 1398–1410.
Song LN . (1994). Effects of retinoic acid and dexamethasone on proliferation, differentiation, and glucocorticoid receptor expression in cultured human osteosarcoma cells. Oncol Res 6: 111–118.
Studzinski GP, Harrison LE . (1999). Differentiation-related changes in the cell cycle traverse. Int Rev Cytol 189: 1–58.
Taichman RS, Emerson SG . (1994). Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor. J Exp Med 179: 1677–1682.
Taichman RS, Reilly MJ, Emerson SG . (1996). Human osteoblasts support human hematopoietic progenitor cells in vitro bone marrow cultures. Blood 87: 518–524.
Taneja R, Rochette-Egly C, Plassat JL, Penna L, Gaub MP, Chambon P . (1997). Phosphorylation of activation functions AF-1 and AF-2 of RAR alpha and RAR gamma is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment. EMBO J 16: 6452–6465.
Tassan JP, Jaquenoud M, Fry AM, Frutiger S, Hughes GJ, Nigg EA . (1995). In vitro assembly of a functional human CDK7-cyclin H complex requires MAT1, a novel 36 kDa RING finger protein. EMBO J 14: 5608–5617.
Thomas D, Kansara M . (2006). Epigenetic modifications in osteogenic differentiation and transformation. J Cell Biochem 98: 757–769.
Traianedes K, Ng KW, Martin TJ, Findlay DM . (1993). Cell substratum modulates responses of preosteoblasts to retinoic acid. J Cell Physiol 157: 243–252.
Wang A, Alimova IN, Luo P, Jong A, Triche TJ, Wu L . (2009). Loss of CAK phosphorylation of RAR\{alpha\} mediates transcriptional control of retinoid-induced cancer cell differentiation. FASEB J (e-pub ahead of print).
Wang J, Barsky LW, Shum CH, Jong A, Weinberg KI, Collins SJ et al. (2002). Retinoid-induced G1 arrest and differentiation activation are associated with a switch to cyclin-dependent kinase-activating kinase hypophosphorylation of retinoic acid receptor alpha. J Biol Chem 277: 43369–43376.
Wang JG, Barsky LW, Davicioni E, Weinberg KI, Triche TJ, Zhang XK et al. (2006). Retinoic acid induces leukemia cell G1 arrest and transition into differentiation by inhibiting cyclin-dependent kinase-activating kinase binding and phosphorylation of PML/RARalpha. FASEB J 20: 2142–2144.
Wang XD . (2005). Alcohol, vitamin A, and cancer. Alcohol 35: 251–258.
Wu L, Chen P, Shum CH, Chen C, Barsky LW, Weinberg KI et al. (2001). MAT1-modulated CAK activity regulates cell cycle G(1) exit. Mol Cell Biol 21: 260–270.
Wu L, Yee A, Liu L, Carbonaro-Hall D, Venkatesan N, Tolo VT et al. (1994). Molecular cloning of the human CAK1 gene encoding a cyclin-dependent kinase-activating kinase. Oncogene 9: 2089–2096.
Zhang S, He Q, Peng H, Tedeschi-Blok N, Triche TJ, Wu L . (2004). MAT1-modulated cyclin-dependent kinase-activating kinase activity cross-regulates neuroblastoma cell G(1) arrest and neurite outgrowth. Cancer Res 64: 2977–2983.
Zhang XK, Lehmann J, Hoffmann B, Dawson MI, Cameron J, Graupner G et al. (1992). Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature 358: 587–591.
Zhu L, Skoultchi AI . (2001). Coordinating cell proliferation and differentiation. Curr Opin Genet Dev 11: 91–97.
Acknowledgements
This study was supported by Grants from the National Institutes of Health R21 CA111440 and R01 CA120512 to L Wu, and 1 UO1 CA114757-01 to TJ Triche.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Luo, P., Yang, X., Ying, M. et al. Retinoid-suppressed phosphorylation of RARα mediates the differentiation pathway of osteosarcoma cells. Oncogene 29, 2772–2783 (2010). https://doi.org/10.1038/onc.2010.50
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.50
Keywords
This article is cited by
-
Nuclear receptor modulators inhibit osteosarcoma cell proliferation and tumour growth by regulating the mTOR signaling pathway
Cell Death & Disease (2023)
-
Inhibition of retinoic acid receptor α phosphorylation represses the progression of triple-negative breast cancer via transactivating miR-3074-5p to target DHRS3
Journal of Experimental & Clinical Cancer Research (2021)
-
The E3 ubiquitin protein ligase MDM2 dictates all-trans retinoic acid-induced osteoblastic differentiation of osteosarcoma cells by modulating the degradation of RARα
Oncogene (2016)
-
Role of osteopontin in osteosarcoma
Medical Oncology (2015)